ISSN (Print):
1871-529X
ISSN (Online):
2212-4063
Download PDF Flyer

Cardiovascular & Hematological Disorders-Drug Targets

All Open Access articles of this journal are also available on ScienceDirect.

(Formerly as Current Drug Targets - Cardiovascular & Hematological Disorders)

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics... View all

Volume 25 , Issues 4, 2025


Institutional Members
Topic(s) Covered

3 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments in the medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders, e.g., disease-specific proteins, receptors, enzymes, and genes. Each issue of the journal contains a series of in-depth/mini-reviews, original research articles, drug clinical trial studies, and guest-edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization, and validation of novel human drug targets for cardiovascular and hematological drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cardiovascular & Hematological Disorders-Drug Targets is an international, peer-reviewed journal on all aspects of cardiovascular and hematological disorders, published quarterly (print & online) by Bentham Science Publishers.

COPE Compliant
Endorsement(s)
"The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."

Garry X. Shen
Univ. of Manitoba, Canada
© 2025 Bentham Science Publishers | Privacy Policy